Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/10/2000DE19901085A1 Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps Transdermal therapeutic system with a self-adhesive matrix containing organic acid-addition salts of morphine alkaloids of the or Morphinantyps
08/10/2000CA2362259A1 Antizyme modulators and their use
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2361838A1 Method of treating cancer by restoration of pp32 function
08/10/2000CA2361816A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000CA2361805A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000CA2361636A1 Use of pyrazole carboxamides
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361581A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention
08/10/2000CA2361578A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention
08/10/2000CA2361575A1 L-arginine based formulations for treating diseases and methods of using same
08/10/2000CA2361572A1 Prevention of abscess formation
08/10/2000CA2361561A1 Immunosurpressive effects of pteridine derivatives
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361539A1 Compressed lecithin preparations
08/10/2000CA2361531A1 Process for extracting polyphenolic antioxidants from purine-containing plants
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2361437A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
08/10/2000CA2361407A1 Pharmaceutical compositions
08/10/2000CA2361191A1 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360941A1 Liposome composition and method for administration of a radiosensitizer
08/10/2000CA2360878A1 Gene repair involving excision of targeting dna
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2360835A1 Method of preparing microparticles of phytosterols or phytostanols
08/10/2000CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000CA2358894A1 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000CA2358892A1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000CA2358891A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000CA2358641A1 Use of cholesterol-lowering agent
08/10/2000CA2358490A1 Anti-plaque emulsions and products containing same
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2356898A1 Indole derivatives and their use as mcp-1 antagonists
08/10/2000CA2355734A1 Indole derivatives as anti-inflammation agents
08/10/2000CA2349703A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
08/10/2000CA2327512A1 Methods for promoting the healing of cutaneous wounds and ulcers using compositions of .alpha.-d-glucans
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
08/09/2000EP1026170A1 Erythromycin derivatives, their preparation and use as medicaments
08/09/2000EP1026167A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
08/09/2000EP1026164A1 Process for extracting polyphenolic antioxidants from purine-containing plants
08/09/2000EP1026150A1 (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same
08/09/2000EP1026149A1 Amidocarboxylic acid derivatives
08/09/2000EP1026147A1 Compounds useful as intermediates in the production of piperidine derivatives
08/09/2000EP1025868A1 Topically applied clotting material
08/09/2000EP1025857A1 Retinoic acid agonists as preventive and therapeutic agents for nephritis
08/09/2000EP1025850A1 Isoflavone-containing compositions
08/09/2000EP1025848A1 Sustained-release theophylline tablet
08/09/2000EP1025846A1 Aqueous liquid preparations
08/09/2000EP1025845A2 Hydromorphone tablets
08/09/2000EP1025844A1 Remedy for hepatopathy
08/09/2000EP1025841A1 Bilayered amoxycillin tablets
08/09/2000EP1025840A2 Oral drug compositions and methods
08/09/2000EP1025838A1 A cosmetic composition and a method for reducing the ageing processes of skin
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025219A2 Antisense oligonucleotide sequences as inhibitors of microorganisms
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025211A2 Hyaluronan synthase gene and uses thereof
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025114A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
08/09/2000EP1025109A1 Benzoxazine derivatives, preparation and application in therapy
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025105A1 Condensed benzothiopyranic compounds
08/09/2000EP1025103A1 Novel polymorphic forms of cipamfylline
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025101A1 Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025099A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025091A1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025089A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
08/09/2000EP1025088A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
08/09/2000EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1025083A1 Process for stereoselective synthesis of prostacyclin derivatives
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024836A1 Method of delivering genes to antigen presenting cells of the skin
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
08/09/2000EP1024833A1 Pharmaceutical composition containing acid addition salt of basic drug
08/09/2000EP1024823A1 Prevention and treatment of adhesion formation
08/09/2000EP1024820A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
08/09/2000EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
08/09/2000EP1024816A1 Kits and methods for alleviation of lower gastrointestinal disorders in a human patient
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024813A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024811A1 Novel benzodiazepine derivatives as antiarrhythmic agents
1 ... 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 6285 ... 7860